Parkwood LLC Arvinas, Inc. Transaction History

Parkwood LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$60.45 - $84.26 $772,127 - $1.08 Million	-12,773 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $743,260 - $1.17 Million	12,773 New	12,773 $844,000
Q4 2020 Feb 12, 2021	SELL	$20.19 - $84.93 $598,916 - $2.52 Million	-29,664 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$22.99 - $36.34 $35,128 - $55,527	1,528 Added 5.43%	29,664 $4.58 Million
Q2 2020 Aug 11, 2020	BUY	$29.88 - $56.74 $840,703 - $1.6 Million	28,136 New	28,136 $944,000

224

70.9M

1.52M

346K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $986M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.